Bank of Nova Scotia
MRK icon

Bank of Nova Scotia’s Merck MRK Stock Holding History

Bank of Nova Scotia’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-52,400
Closed -$3.82M – 903
2018
Q4 		$3.82M Hold
52,400
– – 0.02% 455
2018
Q3 		$3.55M Hold
52,400
– – 0.02% 502
2018
Q2 		$3.04M Hold
52,400
– – 0.02% 423
2018
Q1 		$2.72M Buy
+52,400
New +$2.83M 0.01% 498

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of Nova Scotia's MRK Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Merck (MRK) stake by 26% in Q1 2026, selling an estimated $57.6M and leaving 1,457,238 shares worth $175M. The position accounts for 0.31% of the portfolio, ranked #55.

Bank of Nova Scotia first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $343M in Q4 2023. 3,790 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bank of Nova Scotia held 1,457,238 shares of Merck worth $175M as of Q1 2026.
  • Bank of Nova Scotia sold 498,962 Merck shares in Q1 2026, an estimated $57.6M.
  • Merck made up 0.31% of Bank of Nova Scotia's portfolio in Q1 2026, its #55 holding.
  • Bank of Nova Scotia first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's Merck position peaked at $343M in Q4 2023.
  • 3,790 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.